发明名称 CB1 RECEPTOR MODULATORS
摘要 Compounds of formula (I)wherein Ais -COOH, or tetrazolyl; Ais hydrogen; Ais phenyl optionally substituted with R; Ris hydrogen or C-Calkyl; Ris hydrogen, -F or -Cl; Rand Rare independently hydrogen, C-Calkyl or C-Ccycloalkyl; Ris hydrogen, C-Calkyl or C-Ccycloalkyl fully or partially fluorinated C-Calkyl; Ris (i) -CH-, -CHOH-, or (ii) C(R)(R)-*, -C(R)(R)-O-*, wherein the bond indicated by an asterisk is attached to the pyrazole ring; Ris a divalent radical of formula -Q-[A]; Ais a phenyl or pyridinyl ring optionally having one or more substituent selected from -F, -Cl, -Br, -CN, -CF, C-Calkyl, C-Ccycloalkyl, -OR, oxo or -NRR; v is 1; Qis C(R)(R)-, C(R)(R)CH-; Ris hydrogen and Ris C-Calkyl or Rand Rare both C-Calkyl; or Rand Rtaken together with the carbon atom to which they are attached form a cyclopropyl ring; suppress the normal signalling activity CB1 receptors, and are thus useful in the treatment of diseases or conditions which are mediated by CB1 receptor signalling activity, such as treatment of obesity and overweight, prevention of weigh gain, treatment of diseases and conditions directly or indirectly associated with obesity and overweight.
申请公布号 EA017170(B1) 申请公布日期 2012.10.30
申请号 EA20090000838 申请日期 2007.12.17
申请人 7TM PHARMA A/S 发明人 COOPER MARTIN;RECEVEUR JEAN-MARIE;HOEGBERG THOMAS;NIELSEN PETER, AADAL;LINGET JEAN-MICHEL;NOEREGAARD PIA, KARINA;MURRAY ANTHONY;BJURLING EMELIE
分类号 C07D231/12;A61K31/415;A61K31/4155;A61P3/00;C07D231/18;C07D401/12;C07D403/06 主分类号 C07D231/12
代理机构 代理人
主权项
地址